CLU and Alzheimer disease: CSF PCSK9 levels were increased and positively correlated with apolipoprotein levels in AD patients (apoE4) and cognitively normal subjects at risk for AD (apolipoprotein B, apoE, and apolipoprotein J), indicating PCSK9 dysregulation may be evident before onset of AD.